Open Market Insiders Trades
This list includes insiders general transaction with codes filed in Form 4 from SEC:
- P - Open market or private purchase of non-derivative or derivative security
- S - Open market or private sale of non-derivative or derivative security
- V - Transaction voluntarily reported earlier than required
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
CHWY
|
Sumit Singh
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 7,228 Reduced 1.36% |
$271,122
$37.51 p/Share
|
Jan 16
2025 |
|
SRRK
|
Mo Qatanani
CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct | 7,347 Reduced 5.15% |
$324,737
$44.2 p/Share
|
Jan 16
2025 |
|
SRRK
|
Tracey Sacco
Chief Commercial Officer |
SELL
Open market or private sale
|
Direct | 3,890 Reduced 7.89% |
$171,938
$44.2 p/Share
|
Jan 16
2025 |
|
SRRK
|
Jing L. Marantz
CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct | 5,655 Reduced 7.76% |
$249,951
$44.2 p/Share
|
Jan 16
2025 |
|
SRRK
|
Jay T. Backstrom
CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct | 22,308 Reduced 6.33% |
$986,013
$44.2 p/Share
|
Jan 16
2025 |
|
FIVE
|
Eric M Specter
CAO |
SELL
Open market or private sale
|
Direct | 5,494 Reduced 8.75% |
$498,635
$90.76 p/Share
|
Jan 16
2025 |
|
AEO
|
Cary D Mcmillan
Director |
SELL
Open market or private sale
|
Direct | 2,999 Reduced 100.0% |
$48,043
$16.02 p/Share
|
Jan 16
2025 |
|
SNX
|
Ann F Vezina
Director |
SELL
Open market or private sale
|
Direct | 839 Reduced 14.73% |
$114,171
$136.08 p/Share
|
Jan 16
2025 |
|
ONTO
|
Michael P Plisinski
CEO |
SELL
Open market or private sale
|
Direct | 30,000 Reduced 13.92% |
$6,350,400
$211.68 p/Share
|
Jan 16
2025 |
|
SNX
|
Dennis Polk
Hyve Solutions Executive |
SELL
Open market or private sale
|
Direct | 22,000 Reduced 35.54% |
$3,005,200
$136.6 p/Share
|
Jan 16
2025 |
|
OFIX
|
Julie Andrews
CFO |
SELL
Open market or private sale
|
Direct | 4,655 Reduced 14.12% |
$83,277
$17.89 p/Share
|
Jan 16
2025 |
|
HIMS
|
Andrew Dudum
Chief Executive Officer |
SELL
Open market or private sale
|
Indirect | 47,534 Reduced 0.0% |
$1,289,122
$27.12 p/Share
|
Jan 16
2025 |
|
HIMS
|
Andrew Dudum
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 36,460 Reduced 56.63% |
$990,618
$27.17 p/Share
|
Jan 16
2025 |
|
KLXE
|
Keefer Mc Govern Lehner
Officer |
SELL
Open market or private sale
|
Direct | 2,500 Reduced 2.78% |
$16,675
$6.67 p/Share
|
Jan 16
2025 |
|
CBIO
|
Songjiang Ma
President |
SELL
Open market or private sale
|
Indirect | 2,000 Reduced 0.0% |
$21,420
$10.71 p/Share
|
Jan 16
2025 |
|
PLAB
|
Kang Jyh Lee
CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct | 8,750 Reduced 1.51% |
$213,500
$24.4 p/Share
|
Jan 16
2025 |
|
QK
|
Hrt Financial LP
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 10,654 Added 27.57% |
$9,801
$0.92 p/Share
|
Jan 16
2025 |
|
GRX
|
Mario J Gabelli
Director |
BUY
Open market or private purchase
|
Direct | 4,000 Added 1.67% |
$39,200
$9.8 p/Share
|
Jan 16
2025 |
|
NXJ
|
Saba Capital Management, L.P.
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 50,043 Reduced 0.0% |
$603,518
$12.06 p/Share
|
Jan 16
2025 |
|
MIO
|
Saba Capital Management, L.P.
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 6,637 Added 0.0% |
$78,582
$11.84 p/Share
|
Jan 16
2025 |
|
SCWO
|
Yaacov Nagar |
SELL
Open market or private sale
|
Direct | 300 Reduced 0.0% |
$189
$0.63 p/Share
|
Jan 16
2025 |
|
IZTC
|
Michael Heltzen
Chief Executive Officer |
BUY
Open market or private purchase
|
Direct | 121 Added 5.44% |
$1,297
$10.72 p/Share
|
Jan 16
2025 |
|
QMCO
|
Henk Jan Spanjaard
Chief Revenue Officer |
SELL
Open market or private sale
|
Direct | 935 Reduced 5.9% |
$33,360
$35.68 p/Share
|
Jan 16
2025 |
|
QMCO
|
James J Lerner
President & CEO |
SELL
Open market or private sale
|
Direct | 2,511 Reduced 2.28% |
$89,592
$35.68 p/Share
|
Jan 16
2025 |
|
QMCO
|
Brian E Cabrera
SVP Chief Admin Ofcr & Secy |
SELL
Open market or private sale
|
Direct | 1,996 Reduced 6.67% |
$71,217
$35.68 p/Share
|
Jan 16
2025 |
|
QMCO
|
Kenneth P. Gianella
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 1,487 Reduced 4.23% |
$53,056
$35.68 p/Share
|
Jan 16
2025 |
|
NYC
|
Nicholas S Schorsch
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 1,367 Added 0.0% |
$12,412
$9.08 p/Share
|
Jan 16
2025 |
|
PNRG
|
Clint Hurt
Director |
SELL
Open market or private sale
|
Direct | 739 Reduced 0.56% |
$158,781
$214.86 p/Share
|
Jan 16
2025 |
|
SKYH
|
Boston Omaha Corp
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 23,907 Reduced 0.22% |
$269,431
$11.27 p/Share
|
Jan 16
2025 |
|
IONS
|
Joseph Baroldi
EVP, Chief Business Officer |
SELL
Open market or private sale
|
Direct | 3,401 Reduced 11.97% |
$111,212
$32.7 p/Share
|
Jan 16
2025 |
|
IONS
|
Joseph Baroldi
EVP, Chief Business Officer |
SELL
Open market or private sale
|
Indirect | 1,029 Reduced 0.0% |
$33,648
$32.7 p/Share
|
Jan 16
2025 |
|
IONS
|
C Frank Bennett
EVP, Chief Scientific Officer |
SELL
Open market or private sale
|
Direct | 6,752 Reduced 6.92% |
$222,140
$32.9 p/Share
|
Jan 16
2025 |
|
IONS
|
Brian Birchler
EVP, Corp and Development Ops |
SELL
Open market or private sale
|
Direct | 5,400 Reduced 8.93% |
$176,580
$32.7 p/Share
|
Jan 16
2025 |
|
IONS
|
Shannon L. Devers
EVP, Chief Human Resources Ofc |
SELL
Open market or private sale
|
Direct | 4,267 Reduced 21.12% |
$139,872
$32.78 p/Share
|
Jan 16
2025 |
|
IONS
|
Richard S Geary
EVP, Chief Development Officer |
SELL
Open market or private sale
|
Direct | 7,072 Reduced 6.82% |
$232,385
$32.86 p/Share
|
Jan 16
2025 |
|
IONS
|
Elizabeth L Hougen
EVP, Finance & CFO |
SELL
Open market or private sale
|
Direct | 8,870 Reduced 7.6% |
$291,024
$32.81 p/Share
|
Jan 16
2025 |
|
IONS
|
Brett P Monia
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 33,445 Reduced 13.89% |
$1,091,310
$32.63 p/Share
|
Jan 16
2025 |
|
IONS
|
Patrick R. O'Neil
EVP CLO & General Counsel |
SELL
Open market or private sale
|
Direct | 7,360 Reduced 10.73% |
$241,628
$32.83 p/Share
|
Jan 16
2025 |
|
IONS
|
Eugene Schneider
EVP, Chf Clinical Develop Ofcr |
SELL
Open market or private sale
|
Direct | 6,523 Reduced 10.03% |
$213,889
$32.79 p/Share
|
Jan 16
2025 |
|
IONS
|
Eric Swayze
EVP Research |
SELL
Open market or private sale
|
Direct | 7,154 Reduced 13.54% |
$234,937
$32.84 p/Share
|
Jan 16
2025 |
|
IONS
|
Eric Swayze
EVP Research |
SELL
Open market or private sale
|
Indirect | 22 Reduced 0.0% |
$719
$32.7 p/Share
|
Jan 16
2025 |
|
MRSN
|
Timothy B Lowinger
SVP, Chief Sci.&Tech. Officer |
SELL
Open market or private sale
|
Direct | 8,048 Reduced 3.03% |
$4,667
$0.58 p/Share
|
Jan 16
2025 |
|
MRSN
|
Anna Protopapas
Director |
SELL
Open market or private sale
|
Direct | 8,637 Reduced 4.89% |
$5,009
$0.58 p/Share
|
Jan 16
2025 |
|
MRSN
|
Ashish Mandelia
VP, Chief Accounting Officer |
SELL
Open market or private sale
|
Direct | 3,554 Reduced 5.82% |
$2,061
$0.58 p/Share
|
Jan 16
2025 |
|
MRSN
|
Brian De Schuytner
SVP, COO & CFO |
SELL
Open market or private sale
|
Direct | 8,470 Reduced 6.52% |
$4,912
$0.58 p/Share
|
Jan 16
2025 |
|
MRSN
|
Martin H. Huber Jr.
President, CEO |
SELL
Open market or private sale
|
Direct | 4,514 Reduced 3.54% |
$2,618
$0.58 p/Share
|
Jan 16
2025 |
|
MRSN
|
Mohan Bala
SVP, Chief Development Officer |
SELL
Open market or private sale
|
Direct | 5,939 Reduced 7.94% |
$3,444
$0.58 p/Share
|
Jan 16
2025 |
|
MRSN
|
Alejandra Carvajal
SVP, Chief Legal Officer |
SELL
Open market or private sale
|
Direct | 5,096 Reduced 6.11% |
$2,955
$0.58 p/Share
|
Jan 16
2025 |
|
RXST
|
Jesse Anderson Corley |
BUY
Open market or private purchase
|
Indirect | 1,767 Added 0.0% |
$55,006
$31.13 p/Share
|
Jan 16
2025 |
|
TEM
|
Bradley A Keywell
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 510,364 Reduced 0.0% |
$18,020,952
$35.31 p/Share
|
Jan 16
2025 |